Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response

Published by
Published by: 
Krystle Barbour, Public Relations Coordinator
May 29, 2018

MINNEAPOLIS- May 02, 2018- University of Minnesota Medical School researchers to lead clinical trial for new, minimally invasive heart attack treatment. The University of Minnesota is the first site in the state to test the treatment that has shown improvements in patients’ quality of life and heart function.

The CardiAMP investigational therapy is a minimally invasive treatment for ischemic heart failure which occurs after a heart attack. The therapy includes a pre-procedure screening test. A small bone marrow sample is taken and screened to identify patients with a higher likelihood of benefitting from the treatment.

If a patient with University of Minnesota Health qualifies for the therapy, additional bone marrow is collected, which is immediately processed to concentrate the cells into the therapeutic dosage. The dose is then delivered through a catheterization procedure directly into the damaged portions of the heart. Therefore, the patient’s own cells are used in a therapy designed to stimulate the body’s natural healing response.

"Treatment of heart failure can be very challenging to the patient as well as for the care providers. CardiAMP is an investigational therapy using patients’ own cell lines to treat the failing heart muscle,” said Ganesh Raveendran, MD, Associate Professor of Medicine, Cardiovascular Division, University of Minnesota Medical School. “This therapy, if proven to be successful, could complement the current treatment modalities available to the patient and eventually reduce the need for LVAD therapy and heart transplantation."

Heart failure is a serious, chronic, and progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs, and, for which typically there is no cure. However, many people with heart failure lead full, happy lives when the condition is managed properly. In 2015, an estimated 5.7 million Americans over the age of 20 were reported to have heart failure, according to the American Heart Association (AHA). The prevalence of heart failure continues to increase due to the aging population and the increase in major cardiovascular risk factors, including obesity and diabetes.

Category: 

Share this post

You may also like:

The behavior of people who remain committed to a choice, even when it is clear that an alternate choice would be a better option, has been a perplexing phenomenon to psychologists and economists. 

University of Minnesota Masonic Children's Hospital is the largest treatment center in the United States for patients with the rare genetic disease Fanconi anemia (FA).

The program is aiming to raise $10 million to support the initiative which includes the professorship of the academic study of sexuality and aging.